carbenicillin has been researched along with moxalactam in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (78.95) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (21.05) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amicosante, G; Caporale, B; Celenza, G; Docquier, JD; Mezzatesta, M; Pellegrini, C; Perilli, M; Rossolini, GM; Stefani, S | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Castanheira, M; Samuelsen, Ø; Spencer, J; Walsh, TR | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Kakushi, H; Shike, T; Uchida, K | 2 |
| Ernst, P; Friis, H; Hansen, HH; Hansen, SW; Vejlsgaard, R | 1 |
| Hashimoto, N; Tanaka, H | 1 |
| Alexander, GA; Crawford, SA; Jorgensen, JH | 1 |
| Fox, JM; Quall, CO; Woolfrey, BF | 1 |
| Livermore, DM; Williams, JD; Williams, RJ | 1 |
| Drew, WL; Mintz, L | 1 |
| Neu, HC | 1 |
| Creger, RJ; Falkowski, AJ | 1 |
| Alvarez, S; DeMaria, A; Klein, JO; McCabe, WR | 1 |
| Mirrett, S; Reimer, LG; Reller, LB | 1 |
| Crokaert, F; Labbé, M; Lismont, MJ; Van der Linden, MP; Yourassowsky, E | 1 |
| Tally, FP | 1 |
| Goldner, M; Scudamore, RA | 1 |
1 trial(s) available for carbenicillin and moxalactam
| Article | Year |
|---|---|
Latamoxef versus carbenicillin plus gentamicin or carbenicillin plus mecillinam in leukopenic, febrile patients with solid tumors.
Topics: Adult; Aged; Antineoplastic Agents; Carbenicillin; Cisplatin; Clinical Trials as Topic; Female; Fever; Gentamicins; Humans; Leukopenia; Male; Middle Aged; Moxalactam; Prospective Studies | 1986 |
18 other study(ies) available for carbenicillin and moxalactam
| Article | Year |
|---|---|
Identification and characterization of a new metallo-beta-lactamase, IND-5, from a clinical isolate of Chryseobacterium indologenes.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporins; Chryseobacterium; Flavobacteriaceae Infections; Humans; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillins; Sequence Analysis, DNA | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Kinetic characterization of VIM-7, a divergent member of the VIM metallo-beta-lactamase family.
Topics: Acremonium; Bacterial Proteins; beta-Lactamases; Catalysis; Catalytic Domain; Cefepime; Ceftazidime; Cephalosporins; Kinetics; Models, Molecular; Mutation; Penicillinase; Protein Structure, Tertiary; Recombinant Proteins; Structure-Activity Relationship; Substrate Specificity | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Effects of 1-S replaced and/or decarboxylated latamoxef on rabbit platelet aggregation in vitro.
Topics: Animals; Anti-Bacterial Agents; Aspirin; Carbenicillin; Cefmetazole; Cefotaxime; Cephamycins; In Vitro Techniques; Male; Moxalactam; Platelet Aggregation; Rabbits | 1988 |
Effect of latamoxef (moxalactam) and its related compounds on platelet aggregation in vitro--structure activity relationships.
Topics: Adenosine Diphosphate; Carbenicillin; Cefotaxime; Ceftizoxime; Collagen; Humans; In Vitro Techniques; Male; Moxalactam; Platelet Aggregation; Structure-Activity Relationship | 1987 |
Epimerization kinetics of moxalactam, its derivatives, and carbenicillin in aqueous solution.
Topics: Carbenicillin; Carboxylic Acids; Chemical Phenomena; Chemistry; Freeze Drying; Hydrogen-Ion Concentration; Kinetics; Moxalactam; Solutions; Stereoisomerism | 1985 |
Comparison of moxalactam (LY127935) and cefotaxime against anaerobic bacteria.
Topics: Anaerobiosis; Bacteria; Bacteroides; Carbenicillin; Cefotaxime; Cephalosporins; Cephamycins; Clostridium; Microbial Sensitivity Tests; Moxalactam; Penicillins | 1980 |
Susceptibility of Pseudomonas aeruginosa to cefoperazone, cefotaxime and moxalactam, with special reference to isolates resistant to aminoglycosides, carbenicillin and ticarcillin.
Topics: Carbenicillin; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Dose-Response Relationship, Drug; Moxalactam; Penicillin Resistance; Pseudomonas aeruginosa; Ticarcillin | 1981 |
Comparison of the beta-lactamase stability and the in-vitro activity of cefoperazone, cefotaxime, cefsulodin, ceftazidime, moxalactam and ceftriaxone against Pseudomonas aeruginosa.
Topics: beta-Lactamases; Carbenicillin; Cefoperazone; Cefotaxime; Cefsulodin; Ceftazidime; Ceftriaxone; Cephalosporins; Cephamycins; Moxalactam; Penicillin Resistance; Pseudomonas aeruginosa | 1981 |
Comparative synergistic activity of cefoperazone, cefotaxime, moxalactam, and carbenicillin, combined with tobramycin, against Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Carbenicillin; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Drug Synergism; Microbial Sensitivity Tests; Moxalactam; Penicillin Resistance; Pseudomonas aeruginosa; Tobramycin | 1981 |
Beta-lactamase stability of cefoxitin in comparison with other beta-lactam compounds.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbenicillin; Cefamandole; Cefoperazone; Cefotaxime; Cefoxitin; Cephalosporinase; Gram-Negative Bacteria; Moxalactam; Penicillinase; Piperacillin | 1983 |
Hydroxylamine technique for in vitro prevention of penicillin inactivation of tobramycin.
Topics: Azlocillin; Carbenicillin; Cefamandole; Drug Interactions; Humans; Hydroxylamine; Hydroxylamines; Immunoenzyme Techniques; In Vitro Techniques; Moxalactam; Penicillins; Piperacillin; Ticarcillin; Tobramycin | 1984 |
In vitro studies of moxalactam (LY127935), a new beta-lactam antibiotic with significant activity against gram-negative bacteria.
Topics: Amikacin; Ampicillin; Carbenicillin; Cefoxitin; Cefuroxime; Cephalosporins; Cephamycins; Clindamycin; Gram-Negative Aerobic Bacteria; Gram-Negative Anaerobic Bacteria; Haemophilus influenzae; Moxalactam; Oxacillin | 1980 |
Comparison of in vitro activity of moxalactam (LY127935) with cefazolin, amikacin, tobramycin, carbenicillin, piperacillin, and ticarcillin against 420 blood culture isolates.
Topics: Amikacin; Bacteria; Carbenicillin; Cefazolin; Cephalosporins; Cephamycins; Culture Media; Humans; Microbial Sensitivity Tests; Moxalactam; Penicillins; Piperacillin; Sepsis; Species Specificity; Ticarcillin; Tobramycin | 1980 |
The effect of beta-lactam antibiotics on the growth curves of Bacteroides fragilis, obtained with the MS-2 system.
Topics: Anaerobiosis; Bacteroides fragilis; beta-Lactams; Carbenicillin; Cefoxitin; Cell Division; Cephamycins; Dose-Response Relationship, Drug; Kinetics; Microbial Sensitivity Tests; Moxalactam; Penicillin G | 1981 |
Therapeutic approaches to anaerobic infection.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Carbenicillin; Cefoxitin; Cephamycins; Chloramphenicol; Clindamycin; Drug Combinations; Female; Gastrointestinal Diseases; Genital Diseases, Female; Gram-Negative Anaerobic Bacteria; Humans; Male; Moxalactam; Respiratory Tract Infections; Skin Diseases, Infectious; Suppuration; Ticarcillin | 1981 |
Limited contribution of the outer-membrane penetration barrier towards intrinsic antibiotic resistance of Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Carbenicillin; Cell Membrane Permeability; Cephamycins; Edetic Acid; Erythromycin; Gentamicins; Moxalactam; Penicillin Resistance; Pseudomonas aeruginosa; Tobramycin | 1982 |